Huons Global Co., Ltd. 084110
KRX · South Korea · Health Technology
KRW 22,550.00-400.00 (-1.74%)
Market closed· · KRW · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · KRW · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Total return, dividends included.
Where the price sits against its 50- and 200-day moving averages.
Makkler Fair Value, financial health score, analyst view, peers and MakklerAI.
PANGYO, South Korea, August 31, 2026--Huonslab, the R&D subsidiary of Huons Global, secured patents and PCT filings for 11 SC antibody formulations using HyDIFFUZE™.
PANGYO, South Korea, July 27, 2026--Huonslab, the R&D subsidiary of Huons Group, secures a patent for an ADC subcutaneous formulation using its HyDIFFUZE platform to boost drug delivery.
Recent third-party headlines about this company, kept separate from Makkler's own editorial coverage and linking out to the publisher. Accuracy is the publisher's responsibility.